188 related articles for article (PubMed ID: 31656689)
1. Progressive Ataxia with Elevated Alpha-Fetoprotein: Diagnostic Issues and Review of the Literature.
Paucar M; Taylor AMR; Hadjivassiliou M; Fogel BL; Svenningsson P
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31656689
[TBL] [Abstract][Full Text] [Related]
2. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients.
Anheim M; Monga B; Fleury M; Charles P; Barbot C; Salih M; Delaunoy JP; Fritsch M; Arning L; Synofzik M; Schöls L; Sequeiros J; Goizet C; Marelli C; Le Ber I; Koht J; Gazulla J; De Bleecker J; Mukhtar M; Drouot N; Ali-Pacha L; Benhassine T; Chbicheb M; M'Zahem A; Hamri A; Chabrol B; Pouget J; Murphy R; Watanabe M; Coutinho P; Tazir M; Durr A; Brice A; Tranchant C; Koenig M
Brain; 2009 Oct; 132(Pt 10):2688-98. PubMed ID: 19696032
[TBL] [Abstract][Full Text] [Related]
3. SETX mutations are a frequent genetic cause of juvenile and adult onset cerebellar ataxia with neuropathy and elevated serum alpha-fetoprotein.
Nanetti L; Cavalieri S; Pensato V; Erbetta A; Pareyson D; Panzeri M; Zorzi G; Antozzi C; Moroni I; Gellera C; Brusco A; Mariotti C
Orphanet J Rare Dis; 2013 Aug; 8():123. PubMed ID: 23941260
[TBL] [Abstract][Full Text] [Related]
4. Autosomal Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker.
Renaud M; Tranchant C; Koenig M; Anheim M
Mov Disord; 2020 Dec; 35(12):2139-2149. PubMed ID: 33044027
[TBL] [Abstract][Full Text] [Related]
5. Ataxia with oculomotor apraxia type 2: a clinical and genetic study of 19 patients.
Tazir M; Ali-Pacha L; M'Zahem A; Delaunoy JP; Fritsch M; Nouioua S; Benhassine T; Assami S; Grid D; Vallat JM; Hamri A; Koenig M
J Neurol Sci; 2009 Mar; 278(1-2):77-81. PubMed ID: 19141356
[TBL] [Abstract][Full Text] [Related]
6. Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein.
Mariani LL; Rivaud-Péchoux S; Charles P; Ewenczyk C; Meneret A; Monga BB; Fleury MC; Hainque E; Maisonobe T; Degos B; Echaniz-Laguna A; Renaud M; Wirth T; Grabli D; Brice A; Vidailhet M; Stoppa-Lyonnet D; Dubois-d'Enghien C; Le Ber I; Koenig M; Roze E; Tranchant C; Durr A; Gaymard B; Anheim M
Sci Rep; 2017 Nov; 7(1):15284. PubMed ID: 29127364
[TBL] [Abstract][Full Text] [Related]
7. Ataxia with oculomotor apraxia type 2: novel mutations in six patients with juvenile age of onset and elevated serum alpha-fetoprotein.
Bernard V; Stricker S; Kreuz F; Minnerop M; Gillessen-Kaesbach G; Zühlke C
Neuropediatrics; 2008 Dec; 39(6):347-50. PubMed ID: 19569000
[TBL] [Abstract][Full Text] [Related]
8. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2.
Moreira MC; Klur S; Watanabe M; Németh AH; Le Ber I; Moniz JC; Tranchant C; Aubourg P; Tazir M; Schöls L; Pandolfo M; Schulz JB; Pouget J; Calvas P; Shizuka-Ikeda M; Shoji M; Tanaka M; Izatt L; Shaw CE; M'Zahem A; Dunne E; Bomont P; Benhassine T; Bouslam N; Stevanin G; Brice A; Guimarães J; Mendonça P; Barbot C; Coutinho P; Sequeiros J; Dürr A; Warter JM; Koenig M
Nat Genet; 2004 Mar; 36(3):225-7. PubMed ID: 14770181
[TBL] [Abstract][Full Text] [Related]
9. Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2).
Becherel OJ; Fogel BL; Zeitlin SI; Samaratunga H; Greaney J; Homer H; Lavin MF
Cerebellum; 2019 Jun; 18(3):448-456. PubMed ID: 30778901
[TBL] [Abstract][Full Text] [Related]
10. Ataxia with oculomotor apraxia type 2 caused by a novel homozygous mutation in SETX gene, and literature review.
Chen S; Du J; Jiang H; Zhao W; Wang N; Ying A; Li J; Chen S; Shen B; Zhou Y
Front Mol Neurosci; 2022; 15():1019974. PubMed ID: 36438189
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel senataxin mutations in Chinese patients with autosomal recessive cerebellar ataxias by targeted next-generation sequencing.
Lu C; Zheng YC; Dong Y; Li HF
BMC Neurol; 2016 Sep; 16(1):179. PubMed ID: 27644330
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.
Anheim M; Fleury MC; Franques J; Moreira MC; Delaunoy JP; Stoppa-Lyonnet D; Koenig M; Tranchant C
Arch Neurol; 2008 Jul; 65(7):958-62. PubMed ID: 18625865
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous deletion in exon 6 of
Kinkar JS; Jameel PZ; Kumawat BL; Kalbhor P
BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34193451
[TBL] [Abstract][Full Text] [Related]
14. A novel nonsense mutation in a Japanese family with ataxia with oculomotor apraxia type 2 (AOA2).
Nakamura K; Yoshida K; Makishita H; Kitamura E; Hashimoto S; Ikeda S
J Hum Genet; 2009 Dec; 54(12):746-8. PubMed ID: 19893583
[TBL] [Abstract][Full Text] [Related]
15. A Novel SETX Mutation in a Taiwanese Patient with Autosomal Recessive Cerebellar Ataxia Detected by Targeted Next-Generation Sequencing, and a Literature Review.
Chiang PI; Liao TW; Chen CM
Brain Sci; 2022 Jan; 12(2):. PubMed ID: 35203940
[TBL] [Abstract][Full Text] [Related]
16. ARV1 Gene: A Novel Cause of Autosomal Recessive Cerebellar Ataxia with Elevated Alpha Fetoprotein.
Kamate M; Basavanagowda T
Cerebellum; 2024 Jun; 23(3):1239-1244. PubMed ID: 37749428
[TBL] [Abstract][Full Text] [Related]
17. Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1.
Renaud M; Moreira MC; Ben Monga B; Rodriguez D; Debs R; Charles P; Chaouch M; Ferrat F; Laurencin C; Vercueil L; Mallaret M; M'Zahem A; Pacha LA; Tazir M; Tilikete C; Ollagnon E; Ochsner F; Kuntzer T; Jung HH; Beis JM; Netter JC; Djamshidian A; Bower M; Bottani A; Walsh R; Murphy S; Reiley T; Bieth É; Roelens F; Poll-The BT; Lourenço CM; Jardim LB; Straussberg R; Landrieu P; Roze E; Thobois S; Pouget J; Guissart C; Goizet C; Dürr A; Tranchant C; Koenig M; Anheim M
JAMA Neurol; 2018 Apr; 75(4):495-502. PubMed ID: 29356829
[TBL] [Abstract][Full Text] [Related]
18. Novel SETX variants in a patient with ataxia, neuropathy, and oculomotor apraxia are associated with normal sensitivity to oxidative DNA damaging agents.
Vantaggiato C; Cantoni O; Guidarelli A; Romaniello R; Citterio A; Arrigoni F; Doneda C; Castelli M; Airoldi G; Bresolin N; Borgatti R; Bassi MT
Brain Dev; 2014 Sep; 36(8):682-9. PubMed ID: 24183476
[TBL] [Abstract][Full Text] [Related]
19. Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study.
Criscuolo C; Chessa L; Di Giandomenico S; Mancini P; Saccà F; Grieco GS; Piane M; Barbieri F; De Michele G; Banfi S; Pierelli F; Rizzuto N; Santorelli FM; Gallosti L; Filla A; Casali C
Neurology; 2006 Apr; 66(8):1207-10. PubMed ID: 16636238
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
